You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 2, February 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Venous Thromboembolism
 •Colorectal Surgery
 •Blood/ Coagulation
 •Women's Health
 •Women's Health, Other
 •Hematology/ Hematologic Malignancies
 •Alert me on articles by topic

Association Between Venous Thromboembolism and Perioperative Allogeneic Transfusion

Kent R. Nilsson, MD, MA; Sean M. Berenholtz, MD, MHS; Elizabeth Garrett-Mayer, PhD; Todd Dorman, MD; Michael J. Klag, MD, MPH; Peter J. Pronovost, MD, PhD

Arch Surg. 2007;142(2):126-132.

Hypothesis  Perioperative allogeneic blood product transfusion would be associated with venous thromboembolic complications in surgical patients.

Design  Observational study using a state discharge database.

Setting  Nonfederal acute care hospitals in Maryland performing colorectal cancer resections between January 1, 1994, and December 31, 2000.

Patients  We obtained data on 14 014 adult patients having a primary diagnosis code for colorectal cancer and a primary procedure code for colorectal resection.

Main Outcome Measures  The primary outcome variable was a discharge diagnosis of venous thromboembolism (VTE).

Results  Venous thromboembolism occurred in 1% of patients and was associated with an adjusted 3.8-fold increase in mortality (odds ratio, 3.8; 95% confidence interval, 2.1-6.8), a 61% increase in mean hospital length of stay, and a 72% increase in mean total hospital charges. Risk factors for VTE after adjustment included transfusion, female sex, age 80 years or older, moderate to severe liver disease vs no liver disease, admission through the emergency department, and low annual surgeon case volume. Transfusion was associated with an increase in the odds of developing VTE in women (odds ratio, 1.8; 95% confidence interval, 1.2-2.6) but not in men (odds ratio, 0.9; 95% confidence interval, 0.5-1.9). In the absence of transfusion, female compared with male sex was not associated with an increased risk of VTE (odds ratio, 1.2; 95% confidence interval, 0.8-1.7).

Conclusions  In this large observational study of patients undergoing colorectal cancer resection, perioperative allogeneic blood transfusion was associated with an increased risk of VTE in women but not in men. Given the substantial morbidity and mortality associated with VTE and the implication that this finding has for postoperative management in women, this association must be confirmed in independent studies.


Author Affiliations: Departments of Medicine (Drs Nilsson, Dorman, and Klag), Anesthesiology and Critical Care Medicine (Drs Berenholtz, Dorman, and Pronovost), Surgery (Drs Berenholtz, Dorman, and Pronovost), Oncology (Dr Garrett-Mayer), Health Policy and Management (Drs Klag and Pronovost), and Epidemiology (Dr Klag), The Johns Hopkins University Schools of Medicine, and Hygiene and Public Health, Baltimore, Md.


RELATED ARTICLE

Association Between Venous Thromboembolism and Perioperative Allogeneic Transfusion—Invited Critique
Leigh A. Neumayer
Arch Surg. 2007;142(2):133.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.